Pancreatic Cancer Research

ResearcherAnkara Numune Eğitim ve Araştırma HastanesiActive in the last 2 years

Fahriye Tuğba Köş

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6980-4942; OpenAlex author ID A5064384585. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2012: 3 papers · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 8

  1. Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma. Last author DOI 10.1080/14796694.2026.2732589↗
  2. Predicting survival outcomes in advanced pancreatic cancer using machine learning methods. Co-author DOI 10.1097/md.0000000000043904↗
  3. HALP–GRIms Synergy Offers Superior Prognostic and Predictive Precision in Advanced Pancreatic Ductal Adenocarcinoma First author DOI 10.21203/rs.3.rs-7277845/v1↗
  4. Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer: a retrospective analysis of a multicentre study (Anatolian Society of M… First author DOI 10.5114/wo.2014.43933↗
  5. Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale". Co-author DOI 10.1007/s00508-013-0453-9↗
  6. Is there an association between blood group and survival in pancreatic cancer? Co-author DOI 10.7314/apjcp.2012.13.12.6151↗
  7. Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Med… Co-author DOI 10.7314/apjcp.2012.13.5.1841↗
  8. Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multic… First author PMID 22517701↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. İsmet Seven · 3 shared papers, 2025–2026 · strength 1.21
  2. Berkay Yeşilyurt · 2 shared papers, 2025–2026 · strength 0.93
  3. Doğan Uncu · 3 shared papers, 2012–2025 · strength 0.36
  4. Furkan Ceylan · 1 shared paper, 2025 · strength 0.28
  5. Nuriye Özdemir · 4 shared papers, 2012–2014 · strength 0.12
  6. Velı Berk · 3 shared papers, 2012–2015 · strength 0.10
  7. Ali̇ İnal · 3 shared papers, 2012–2015 · strength 0.10
  8. Abdurrahman Işıkdoğan · 3 shared papers, 2012–2015 · strength 0.10
  9. Nurullah Zengin · 2 shared papers, 2012–2014 · strength 0.08
  10. Metin Özkan · 2 shared papers, 2012 · strength 0.05
  11. Mahmut Gümüş · 2 shared papers, 2012 · strength 0.05
  12. Gamze Göksel Ozturk · 1 shared paper, 2012 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.